
Location: Central Territory (Remote)
Reporting to: Director, Thought Leader Marketing and Engagement
ITF Therapeutics is seeking candidates for the role of Thought Leader Liaison covering the central region of the country. The Thought Leader Liaison (TLL) is a field-based marketing role responsible for developing and maintaining strategic relationships with key opinion leaders (KOLs), emerging experts, and influential healthcare professionals within DMD. The TLL serves as the commercial organization's primary point of contact for high-priority thought leaders and acts as the field-based extension of Marketing.
Working cross-functionally with Sales, Medical Affairs, Market Access, Patient Advocacy, and Marketing, the TLL drives strategic engagement, generates marketplace insights, supports speaker development, and facilitates compliant interactions that advance business objectives while maintaining adherence to all legal, regulatory, and compliance requirements.
The base compensation range for this role is: $220,000 - $250,000. Compensation is determined through an analytical approach utilizing a combination of factors including, but not limited to, relevant skills & experience, job location, and internal equity.

ITF Therapeutics is the US-based rare disease division of Italfarmaco S.p.A. Founded in 1938 in Milan, Italy, Italfarmaco is a private global pharmaceutical company that has led the successful development of many innovative therapeutic products approved for use by patients around the world. The company operates in more than 90 countries on five continents and continues to advance promising research to address unmet medical needs in a wide range of therapeutic areas.
In January 2024, Italfarmaco launched ITF Therapeutics as a new division in the United States with a focus on the development and commercialization of products to treat rare diseases. Building on a legacy grounded in collaboration and innovation, ITF Therapeutics strives to partner with leaders from the US patient advocacy and treatment communities to ensure that our programs reflect and support their unique needs and goals. The establishment of ITF Therapeutics reflects Italfarmaco’s goal to build a world- class team of experts who share a passion to make a positive impact for rare disease communities.